Login
Enovis Corp logo

Enovis Corp

enovis.com

Enovis Corp (NYSE: ENOV) is a medical technology company. The filing excerpts provided do not contain sufficient detail to construct a fully source-grounded canonical description covering revenue model, segment breakdown, competitive position, headquarters, founding year, or leadership. All available excerpt content relates only to SEC cover-page boilerplate from the 10-K filed 2026-02-26 (accession 000142080026000012) for fiscal year ended December 31, 2025, and does not include the substantive business description sections required to meet the writing standards. A description cannot be responsibly completed from these excerpts alone.

Financial Snapshot

Revenue
TTM
$2.285B
Gross Margin
TTM
60.72%
Net Income
TTM
-$617.8M
Current Assets
2026 Q3
Current Liabilities
2026 Q3
Current Ratio
2026 Q3
198.46%
Total Assets
2026 Q3
Total Liabilities
2026 Q3
Book Value
2026 Q3
$1.479B
Cash
2026 Q3
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$34.77M

Stock Price

Loading...
Market Cap: $1.5029 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support